Back to
MetLife Investment Management, LLC
PRTA
Showing 8 of 30 quarters
Position history for
MetLife Investment Management, LLC's holdings in PROTHENA CORP PLC
Yes. MetLife Investment Management holds 25,890 shares of PRTA (Prothena), worth $253,463, as of its Q2 2026 13F filing. It increased the position by 6,374 shares (+32.7%) from Q1 2026. MetLife Investment Management has held PRTA in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$253,463
Current Shares
25,890
Total Value Change
-$170,425
Total Shares Change
+553
Quarter-by-Quarter History